Author | Robert L. Redner, MD | OncLive

Author | Robert L. Redner, MD

Articles

Dr. Redner on the Activity of Venetoclax in AML

August 29, 2019

Video

Robert L. Redner, MD, a medical oncologist and hematologist, and professor of medicine, at the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, discusses the activity of venetoclax (Venclexta) in acute myeloid leukemia (AML).

Dr. Redner on the Potency of Gilteritinib in AML

July 19, 2019

Video

Robert L. Redner, MD, a medical oncologist and hematologist, and professor of medicine, at the University of Pittsburgh Medical Center Hillman Cancer Center, discusses the potency of gilteritinib (Xospata) in acute myeloid leukemia (AML).

x